SCHEMBL24792233

SCHEMBL24792233

CCCCCC(CCC)N1CC2(CCOC[C@@H]2N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23865782 0.89 — —
SCHEMBL22778851 0.77 — —
SCHEMBL23746508 0.76 JAK2 (0.34) —
SCHEMBL18969324 0.75 — —
SCHEMBL22778852 0.73 DNM1 (0.31) —
SCHEMBL22778595 0.71 OPRM1 (0.33) —
SCHEMBL23746507 0.71 — —
SCHEMBL22000500 0.70 FDPS (0.32) —
SCHEMBL23219733 0.70 FDPS (0.33) —
SCHEMBL18390359 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402950-A1 SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2022-12-22 — — US disclosed
Send feedback